Concentrix (NASDAQ:CNXC) Stock Price Down 5.4% Following Weak Earnings

Concentrix Corporation (NASDAQ:CNXC)’s stock price dropped 5.4% during trading on Wednesday following a dissappointing earnings announcement. The stock traded as low as $25.44 and last traded at $25.0570. Approximately 1,952,025 shares traded hands during trading, an increase of 33% from the average daily volume of 1,467,669 shares. The stock had previously closed at $26.48.

The company reported $2.61 earnings per share for the quarter, missing the consensus estimate of $2.65 by ($0.04). The business had revenue of $2.50 billion during the quarter, compared to analysts’ expectations of $2.49 billion. Concentrix had a positive return on equity of 17.80% and a negative net margin of 13.35%.The company’s revenue was up 5.4% on a year-over-year basis. During the same quarter in the previous year, the company posted $2.79 earnings per share.

Concentrix Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, May 5th. Stockholders of record on Friday, April 24th will be issued a dividend of $0.36 per share. The ex-dividend date is Friday, April 24th. This represents a $1.44 dividend on an annualized basis and a dividend yield of 5.8%. Concentrix’s dividend payout ratio is currently -6.91%.

Trending Headlines about Concentrix

Here are the key news stories impacting Concentrix this week:

• Positive Sentiment: Revenue and business momentum — Q1 revenue rose 5.4% year-over-year and management cites strong enterprise iX Suite wins and continued AI adoption, showing demand for Concentrix’s higher-value solutions. GlobeNewswire: Q1 Results
• Positive Sentiment: Capital return actions — the company declared a $0.36 quarterly dividend (≈5.3% yield) and repurchased ~1M shares in Q1, supporting shareholder income and signaling confidence in the business. Dividend & buyback detail
• Neutral Sentiment: Company guidance maintained full-year revenue and non-GAAP EPS ranges, but Q2 guidance implies modest constant‑currency growth and lower near-term margins — investors are parsing the recovery timeline. See management’s outlook in the release. Guidance
• Neutral Sentiment: Analyst activity is mixed: several firms trimmed price targets but left buy/outperform ratings, creating dispersion in street expectations (see Benzinga summaries). Analyst PT changes
• Negative Sentiment: Margin compression and EPS miss — Q1 non-GAAP operating margin fell ~180–240 bps and GAAP EPS missed estimates; operating income and net income declined sharply (operating income down ~30%, net income down ~69%), which directly pressured the stock. Yahoo: Margin squeeze story
• Negative Sentiment: Cash-flow and leverage concerns — Q1 used cash from operations and adjusted free cash flow was negative; debt-related costs and recent early note redemption added charges. Analysts warn high leverage and negative near‑term FCF increase execution risk. QuiverQuant: cash flow & earnings detail
• Negative Sentiment: Analyst skepticism and downgrades — independent pieces and at least one downgrade argue the transition to AI-driven services is complex and costly, keeping a “hold” view until margins and cash flow recover in H2 2026. That contributed to selling pressure. Seeking Alpha: Downgrade
• Neutral Sentiment: Market data oddities — multiple short‑interest notices in feeds appear inconsistent (zero reported shares), so short‑interest signals are not reliable for today’s move. (Data sources cited in news entries.)

Analyst Ratings Changes

CNXC has been the topic of several research analyst reports. Robert W. Baird reduced their price objective on shares of Concentrix from $52.00 to $40.00 and set an “outperform” rating on the stock in a report on Wednesday. Barrington Research dropped their price target on shares of Concentrix from $62.00 to $38.00 and set an “outperform” rating for the company in a research report on Wednesday. Canaccord Genuity Group reduced their price target on shares of Concentrix from $80.00 to $55.00 and set a “buy” rating on the stock in a research note on Wednesday. Wall Street Zen upgraded shares of Concentrix from a “hold” rating to a “buy” rating in a report on Saturday, February 14th. Finally, Weiss Ratings cut shares of Concentrix from a “hold (c-)” rating to a “sell (d)” rating in a research report on Thursday, January 29th. Three research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, Concentrix currently has a consensus rating of “Hold” and an average target price of $48.50.

Insider Activity at Concentrix

In related news, CEO Christopher A. Caldwell acquired 1,000 shares of the stock in a transaction dated Thursday, January 29th. The stock was acquired at an average cost of $37.07 per share, with a total value of $37,070.00. Following the completion of the transaction, the chief executive officer owned 362,075 shares in the company, valued at $13,422,120.25. This represents a 0.28% increase in their position. The purchase was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Corporate insiders own 0.90% of the company’s stock.

Institutional Inflows and Outflows

A number of institutional investors have recently added to or reduced their stakes in the company. Hussman Strategic Advisors Inc. acquired a new stake in shares of Concentrix in the 3rd quarter valued at $1,938,000. Allspring Global Investments Holdings LLC purchased a new stake in shares of Concentrix during the 3rd quarter worth $9,627,000. Capital Management Corp VA grew its stake in shares of Concentrix by 45.0% during the third quarter. Capital Management Corp VA now owns 472,681 shares of the company’s stock worth $21,814,000 after purchasing an additional 146,688 shares in the last quarter. Natixis acquired a new position in shares of Concentrix during the second quarter worth $1,872,000. Finally, Arrowstreet Capital Limited Partnership increased its holdings in Concentrix by 247.2% in the second quarter. Arrowstreet Capital Limited Partnership now owns 535,843 shares of the company’s stock valued at $28,322,000 after buying an additional 381,497 shares during the last quarter. Hedge funds and other institutional investors own 90.34% of the company’s stock.

Concentrix Stock Performance

The company has a debt-to-equity ratio of 1.43, a current ratio of 1.18 and a quick ratio of 1.40. The company has a market capitalization of $1.51 billion, a price-to-earnings ratio of -1.14, a PEG ratio of 0.28 and a beta of 0.50. The stock has a 50 day simple moving average of $35.01 and a two-hundred day simple moving average of $40.22.

About Concentrix

Concentrix Inc (NASDAQ: CNXC) is a global business services company specializing in customer engagement solutions and technology‐driven business process outsourcing. The firm’s offerings encompass customer care delivered across voice and digital channels, back‐office processing, analytics and consulting, and automated workflow management. By integrating proprietary platforms, strategic partnerships and advanced automation, Concentrix helps clients enhance customer experiences and streamline operations.

Its capabilities extend to digital marketing and technology implementation, leveraging artificial intelligence, machine learning and data analytics to optimize customer journeys.